Ferrari R, Visioli O
Cattedra di Cardiologia, Università degli Studi di Brescia, Italy.
Cardiovasc Drugs Ther. 1991 Oct;5(5):939-45. doi: 10.1007/BF00053556.
There are several potential outcomes of myocardial ischemia. When ischemia is severe and prolonged, irreversible damage occurs and there is no recovery of contractile function. Interventions aimed at reducing mechanical activity and oxygen demand, either before ischemia or during reperfusion, have been shown to delay the onset of ischemic damage and to improve recovery on reperfusion. When myocardial ischemia is less severe but still prolonged, myocytes may remain viable but exhibit depressed contractile function. Under these conditions, reperfusion restores complete contractile performance. This type of ischemia, leading to a reversible, chronic left ventricular dysfunction, has been termed hibernating myocardium. Depression of mechanical activity is, actually, a protective mechanism whereby the hibernating cells reduce their oxygen demands in the setting of reduced oxygen supply. A third possible outcome after a short period of myocardial ischemia is a transient postischemic ventricular dysfunction, a situation termed stunned myocardium. As in the case of hibernating myocardium, the depressed contractile function occurring during stunning could be a protective mechanism, allowing the reperfused cells to gradually recover their metabolism and function.
心肌缺血有几种潜在的结果。当缺血严重且持续时间较长时,会发生不可逆损伤,收缩功能无法恢复。无论是在缺血前还是再灌注期间,旨在降低机械活动和氧需求的干预措施已被证明可延迟缺血损伤的发生,并改善再灌注时的恢复情况。当心肌缺血不太严重但仍持续较长时间时,心肌细胞可能仍保持存活,但收缩功能会受到抑制。在这些情况下,再灌注可恢复完全的收缩性能。这种导致可逆性慢性左心室功能障碍的缺血类型被称为冬眠心肌。实际上,机械活动的抑制是一种保护机制,通过这种机制,冬眠细胞在氧供应减少的情况下降低其氧需求。短时间心肌缺血后的第三种可能结果是短暂的缺血后心室功能障碍,这种情况被称为心肌顿抑。与冬眠心肌的情况一样,顿抑期间发生的收缩功能抑制可能是一种保护机制,使再灌注的细胞能够逐渐恢复其代谢和功能。